Processa Pharmaceuticals, Inc.
PCSA· Nasdaq
PCSAProcessa Pharmaceuticals, Inc.
Quarterly figures for Processa Pharmaceuticals, Inc., with source filings when available.
57 quarters. Jun 30, 2012 to Jun 30, 2026. USD.
Processa Pharmaceuticals, Inc. has filed its 10-Q within 30 to 45 days of period end across its last 8 quarters. The 10-K runs 66 to 89 days.
Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | — | — | -$1.19 | |
| Mar 31, 2026 |
| — |
| May 7, 2026 |
| 37 d |
| 10-Q |
| — |
| — |
| -$1.29 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | — | Mar 18, 2026 | 77 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 6, 2025 | 37 d | 10-Q | — | — | -$0.07 | |
| Q2 2025 | Jun 30, 2025 | — | Aug 7, 2025 | 38 d | 10-Q | — | — | -$6.26 | |
| Q1 2025 | Mar 31, 2025 | — | May 8, 2025 | 38 d | 10-Q | — | — | -$7.58 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | — | Mar 20, 2025 | 79 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Oct 30, 2024 | 30 d | 10-Q | — | — | -$1.03 | |
| Q2 2024 | Jun 30, 2024 | — | Aug 13, 2024 | 44 d | 10-Q | — | — | -$1.01 | |
| Q1 2024 | Mar 31, 2024 | — | May 10, 2024 | 40 d | 10-Q | — | — | -$1.11 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | Mar 29, 2024 | 89 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | $0.00 | — | -$1.54 | |
| Q2 2023 | Jun 30, 2023 | — | Aug 10, 2023 | 41 d | 10-Q | $0.00 | — | -$1.94 | |
| Q1 2023 | Mar 31, 2023 | — | May 15, 2023 | 45 d | 10-Q | $0.00 | — | -$3.53 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | Mar 30, 2023 | 89 d | 10-K | $0.00 | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · after-hours | Nov 8, 2022 | 39 d | 10-Q | $0.00 | — | -$0.37 | |
| Q2 2022 | Jun 30, 2022 | — | Aug 11, 2022 | 42 d | 10-Q | $0.00 | — | -$0.32 | |
| Q1 2022 | Mar 31, 2022 | — | May 12, 2022 | 42 d | 10-Q | $0.00 | — | — | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Mar 30, 2022 | 89 d | 10-K | $0.00 | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 12, 2021 | 43 d | 10-Q | $0.00 | — | -$0.19 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 12, 2021 | 43 d | 10-Q | — | — | -$0.20 | |
| Q1 2021 | Mar 31, 2021 | — | May 13, 2021 | 43 d | 10-Q | — | — | -$0.14 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 25, 2021 | 84 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 12, 2020 | 43 d | 10-Q | — | — | -$0.55 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 5, 2020 | 36 d | 10-Q | — | — | -$0.13 | |
| Q1 2020 | Mar 31, 2020 | — | May 15, 2020 | 45 d | 10-Q | — | — | -$0.16 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | Mar 6, 2020 | 66 d | 10-K | — | — | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 14, 2019 | 45 d | 10-Q | — | — | -$0.16 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 14, 2019 | 45 d | 10-Q | — | — | -$0.18 | |
| Q1 2019 | Mar 31, 2019 | — | May 14, 2019 | 44 d | 10-Q | — | — | -$0.14 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | Mar 28, 2019 | 87 d | 10-K | — | — | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 14, 2018 | 45 d | 10-Q | — | — | -$0.02 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 14, 2018 | 45 d | 10-Q | — | — | -$0.03 | |
| Q1 2018 | Mar 31, 2018 | — | May 21, 2018 | 51 d | 10-Q | — | — | -$0.03 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | — | Apr 16, 2018 | 106 d | 10-K | — | — | -$0.02 | |
| Q3 2017 | Sep 30, 2017 | — | Nov 20, 2017 | 51 d | 10-Q | — | — | -$0.02 | |
| Q2 2017 | Jun 30, 2017 | — | Oct 4, 2017 | 96 d | 10-Q | — | — | -$0.01 | |
| Q1 2017 | Mar 31, 2017 | — | Oct 4, 2017 | 187 d | 10-Q | — | — | -$0.01 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Sep 25, 2017 | 268 d | 10-K | $0.00 | — | -$0.01 | |
| Q3 2016 | Sep 30, 2016 | — | Sep 8, 2017 | 343 d | 10-Q | $0.00 | −100.0% | -$0.03 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 30, 2017 | 426 d | 10-Q | $0.00 | −100.0% | -$0.02 | |
| Q1 2016 | Mar 31, 2016 | — | Aug 7, 2017 | 494 d | 10-Q | $5.00K | −86.8% | -$0.01 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | Jun 19, 2017 | 536 d | 10-K | — | — | — | |
| Q3 2015 | Sep 30, 2015 | — | Dec 1, 2015 | 62 d | 10-Q | $58.17K | +10.5% | -$0.03 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 19, 2015 | 50 d | 10-Q | $20.04K | −82.2% | -$0.19 | |
| Q1 2015 | Mar 31, 2015 | — | May 15, 2015 | 45 d | 10-Q | $37.76K | +84.8% | -$0.06 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | Apr 14, 2015 | 104 d | 10-K | — | — | — | |
| Q3 2014 | Sep 30, 2014 | — | Nov 13, 2014 | 44 d | 10-Q | $52.62K | −58.2% | -$0.10 | |
| Q2 2014 | Jun 30, 2014 | — | Aug 19, 2014 | 50 d | 10-Q | $112.84K | +16.0% | -$0.11 | |
| Q1 2014 | Mar 31, 2014 | — | May 14, 2014 | 44 d | 10-Q | $20.44K | +6.4% | -$0.17 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | Mar 27, 2014 | 86 d | 10-K | $70.09K | — | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 8, 2013 | 39 d | 10-Q | $125.91K | +156.7% | -$0.12 | |
| Q2 2013 | Jun 30, 2013 | — | Aug 8, 2013 | 39 d | 10-Q | $97.28K | +0.3% | -$0.34 | |
| Q1 2013 | Mar 31, 2013 | — | — | — | — | $19.20K | — | -$0.48 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 31, 2012 | — | — | — | — | — | — | — | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | $49.06K | — | -$0.40 | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | $97.02K | — | -$0.31 | |
